Advances in Research on Lipid-Lowering Mechanisms of Eight Medicinal Plants

被引:0
|
作者
Yang, Huangqizi [1 ]
机构
[1] Jiangxi Univ Tradit Chinese Med, Sch Pharm, Nanchang 330004, Jiangxi, Peoples R China
关键词
Hyperlipidemia; Herbs; Lipid-Lowering Active Ingredients; Lipid-Lowering Mechanisms; INDUCED OXIDATIVE STRESS; INSULIN-RESISTANCE; BETA-CELL; GREEN TEA; HIGH-FAT; INTESTINAL-ABSORPTION; CISSAMPELOS-PAREIRA; ZINGIBER-OFFICINALE; ETHANOLIC EXTRACT; LEAF EXTRACT;
D O I
10.1063/1.5085520
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Hyperlipidemia is a disease of fat metabolism or abnormal operation in healthcare, characterized by one or more of high total cholesterol (TC), high triglycerides (TG), high low-density lipoprotein cholesterol (LDL-C) and low high-density lipoprotein cholesterol (HDL-C) in blood. Hyperlipidemia is prone to cardiovascular and cerebrovascular diseases, obesity, diabetes, hyperinsulinemia and other diseases, posing a serious threat to human health. However, the commonly used chemical synthetic lipid-lowering drugs have obvious clinical effects, but the effect is biased to single and adverse reactions, such as adverse reactions of the nervous system, gastrointestinal reactions and liver damage. In recent years, a large number of literatures had reported that various medicinal plants or their active ingredients had lipid-lowering effects. Thus, finding safe and effective lipid-lowering components from natural medicines has a broad development prospects in research. In this review, I tried to explore the information of several active components of lipid-lowering plants and their lipid-lowering mechanisms, which may help future researchers develop new natural lipid-lowering drugs to treat hyperlipidemia.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Advances in Research on Marine-Derived Lipid-Lowering Active Substances and Their Molecular Mechanisms
    Liu, Lina
    Chen, Yihui
    Chen, Bei
    Xu, Min
    Liu, Shuji
    Su, Yongchang
    Qiao, Kun
    Liu, Zhiyu
    NUTRIENTS, 2023, 15 (24)
  • [2] MECHANISMS OF LIPID-LOWERING AGENTS
    SIRTORI, CR
    MANZONI, C
    LOVATI, MR
    CARDIOLOGY, 1991, 78 (03) : 226 - 235
  • [3] Advances in lipid-lowering therapy in atherosclerosis
    Davignon, J
    DIABETES AND CARDIOVASCULAR DISEASE: ETIOLOGY, TREATMENT, AND OUTCOMES, 2001, 498 : 49 - 58
  • [4] Potential Lipid-Lowering Mechanisms of Biochanin A
    Xue, Zhaohui
    Zhang, Qian
    Yu, Wancong
    Wen, Haichao
    Hou, Xiaonan
    Li, Dan
    Kou, Xiaohong
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2017, 65 (19) : 3842 - 3850
  • [5] Plaque stabilization: Mechanisms of lipid-lowering therapy
    不详
    INTERNIST, 1997, 38 (01): : 4 - 4
  • [6] Advances in the Study of Marine Products with Lipid-Lowering Properties
    Zhao, Jiarui
    Cao, Qi
    Xing, Maochen
    Xiao, Han
    Cheng, Zeyu
    Song, Shuliang
    Ji, Aiguo
    MARINE DRUGS, 2020, 18 (08)
  • [7] Moving Targets: Recent Advances in Lipid-Lowering Therapies
    Larsen, Lars E.
    Stoekenbroek, Robert M.
    Kastelein, John J. P.
    Holleboom, Adriaan G.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2019, 39 (03) : 349 - 359
  • [8] Mechanisms for the reduction in cardiac events with lipid-lowering therapy
    Maciejko, JJ
    JOURNAL OF CLINICAL LIGAND ASSAY, 1997, 20 (01): : 132 - 135
  • [9] Basic mechanisms of stroke prevention with lipid-lowering therapy
    Rosenson R.S.
    Current Atherosclerosis Reports, 2000, 2 (2) : 120 - 125
  • [10] Advances with lipid-lowering drugs for pediatric patients with familial hypercholesterolemia
    Ferrari, Filipe
    Martins, Vitor M.
    Rocha, Viviane Z.
    Santos, Raul D.
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (04) : 483 - 495